Pune: Emcure Pharmaceuticals Limited has announced the incorporation of a new wholly-owned subsidiary named Emcure Wellness Private Limited. The new entity was officially incorporated on July ...

Indian equity markets may begin trade on a muted note, tracing mixed global cues. The GIFT Nifty was down 0.17% at 25516.7 while SGX Nifty was up 0.08% on Friday. Here are the stocks to watch out for ...

Pune: Emcure Pharma has announced the appointment of R.S. Vasan as President - India Business and Senior Management Personnel ...

Emcure Pharma stock was quoting at ₹1,382.5, up 1.5 per cent from the previous day's close of ₹1,362.5 as the company ...

Emcure Pharmaceuticals, a Pune-based company and a powerhouse in the pharmaceutical industry, has received approval from the market regulator SEBI to launch its much anticipated Initial Public ...

Emcure Pharma IPO price band The IPO is priced in the range of Rs 960-1008 per share, where investors can bid for 14 shares in one lot. At the upper end, the company plans to raise Rs 1952 crore ...

Emcure Pharmaceuticals and Sanofi India have partnered in an exclusive distribution and promotion agreement for Sanofi's oral ...

Emcure also has operations in Canada, having acquired Ottawa-based International Pharmaceutical Generics and its marketing operation Marcan Pharmaceuticals in 2016.

Emcure Pharmaceuticals Limited announced the appointment of Mr. R.S. Vasan as President - India Business and Senior ...

Emcure signs exclusive agreement with Sanofi India to distribute and promote its oral anti-diabetic brands Amaryl and Cetapin ...

New Delhi: Emcure Pharmaceuticals on Wednesday said it has launched generic version of sucroferric oxyhydroxide tablets, indicated for the control of increased serum phosphorus levels in patients ...